Loading company…
Jerusalem-based medical imaging company with a digital 3D tomosynthesis system and AI tools for early disease detection.
Nano-X Imaging Ltd. was founded in 2012 and is led by CEO Erez Meltzer. Its FDA-cleared digital multi-source 3D tomosynthesis system uses low-voltage silicon-based technology to produce high-resolution images at reduced radiation doses, and Nanox.AI tools aim to detect chronic diseases early. The company completed 6 deals, most recently on August 21, 2020, and raised USD 193.22 mn in an IPO. It reported 2022 revenue of USD 8.58 mn and EBITDA of USD -104.80 mn.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in